Nanalysis Scientific Corp.
NSCIF
$0.09
$0.00-3.71%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 3.91% | -12.77% | -13.01% | -17.46% | -10.84% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 3.91% | -12.77% | -13.01% | -17.46% | -10.84% |
| Cost of Revenue | 8.33% | -3.58% | -5.17% | -13.17% | -15.99% |
| Gross Profit | -8.88% | -30.56% | -32.87% | -28.48% | 8.43% |
| SG&A Expenses | -18.56% | -24.20% | -19.06% | -5.24% | -2.07% |
| Depreciation & Amortization | 1.52% | -52.66% | -25.14% | -10.03% | -25.56% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.17% | -12.95% | -10.62% | -9.91% | -14.89% |
| Operating Income | 15.21% | -6.48% | -14.34% | -71.93% | 41.35% |
| Income Before Tax | -2.21% | 90.00% | 10.46% | -6.57% | 53.14% |
| Income Tax Expenses | -24.12% | 40.41% | 427.27% | -459.09% | 525.42% |
| Earnings from Continuing Operations | -1.15% | 90.18% | 9.65% | -5.20% | 51.32% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1.15% | 90.18% | 9.65% | -5.20% | 51.32% |
| EBIT | 15.21% | -6.48% | -14.34% | -71.93% | 41.35% |
| EBITDA | -431.67% | -21.04% | -785.09% | -1,814.27% | 76.10% |
| EPS Basic | 16.25% | 90.45% | 11.21% | -4.65% | 55.80% |
| Normalized Basic EPS | 14.58% | 21.62% | 9.68% | -19.18% | 54.72% |
| EPS Diluted | 10.00% | 84.71% | 35.37% | 0.68% | 55.80% |
| Normalized Diluted EPS | 14.58% | 21.62% | 9.68% | -19.18% | 54.72% |
| Average Basic Shares Outstanding | 20.90% | 3.61% | 1.52% | 0.45% | 9.65% |
| Average Diluted Shares Outstanding | 20.90% | 3.61% | 1.52% | 0.45% | 9.65% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |